NCT06496386

Brief Summary

The study is a retrospective observational study. The study is designed to be multicentric and it will analyze medical records from selected patients that underwent major lung resection using DaVinci surgical platform performed in the participating centers. There are no risks for the patients, as this is a retrospective data collection.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
386

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Sep 2024Oct 2026

First Submitted

Initial submission to the registry

June 28, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 11, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 30, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Expected
Last Updated

November 27, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

June 28, 2024

Last Update Submit

November 26, 2024

Conditions

Keywords

robot-assisted thoracoscopic surgerylung resection

Outcome Measures

Primary Outcomes (3)

  • The perioperative complications

    the investigators will measure the perioperative complications of robotic lung resection in patients with 80 or more than 80 years (very elderly patients) compared to those with less than 80 years. Complications will be categorized according to the Clavien-Dindo scale.

    from the surgery at 30-90 days after

  • spirometry tests

    the investigators will measure the pre-operative respiratory function (Forced expiratory volume (FEV) , forced vital capacity (FVC)), in the two groups .

    from hospitalizzation to the discharge date at maximum one week

  • Postoperative hospital stay

    the investigators will measure the post-operative hospital stay in days in the two groups.

    from hospitalizzation to the discharge date at maximum one week

Study Arms (2)

very elderly patients

patients older than 80 years

elderly patients

patients younger than 80 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

the study will focus on the population of subjects undergoing lung resection with the DaVinci surgical platform from May 2015 to December 2022. The anatomical resections considered will be segmentectomy, lobectomy, bilobectomy or pneumonectomy using robotic system.

You may qualify if:

  • Age \>18 years at the moment of surgery
  • Suspected or confirmed diagnosis of lung cancer
  • The patient can be candidate in terms of cardiac, kidney, liver and respiratory function the primary pathology is under control or controllable
  • Absence of extrapulmonary metastases that are not controlled or controllable
  • All procedures included use of DaVinci robot system

You may not qualify if:

  • Age \< 18 years at the moment of surgery
  • Patients who cannot undergo surgery, as they do not meet the conditions outlined above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Istituto Clinico Humanitas

Rozzano, Milan, 20089, Italy

RECRUITING

Scientific Institute Ospedale San Raffaele

Milan, 20132, Italy

RECRUITING

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Pierluigi Novellis, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

June 28, 2024

First Posted

July 11, 2024

Study Start

September 30, 2024

Primary Completion

September 30, 2025

Study Completion (Estimated)

October 31, 2026

Last Updated

November 27, 2024

Record last verified: 2024-11

Locations